Mantle Cell Lymphoma (MCL) Withdrawn Phase 1 / 2 Trials for Temsirolimus (DB06287)

Also known as: Mantle Cell Lymphomas / Lymphoma, Mantle-Cell / Mantle-Cell Lymphoma / Lymphoma, Mantle Cell / Mantle Cell Lymphoma / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS

DBCOND0071979 (Mantle Cell Lymphoma (MCL))Withdrawn1 / 2 IdentifierTitlePurposeDrugs
NCT01170052Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)Treatment